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Epigenetic processes play a key role in orchestrating transcriptional regulation during development. The importance of
DNA methylation in fetal brain development is highlighted by the dynamic expression of de novo DNA methyl-
transferases during the perinatal period and neurodevelopmental deficits associated with mutations in the methyl-CpG
binding protein 2 (MECP2) gene. However, our knowledge about the temporal changes to the epigenome during fetal brain
development has, to date, been limited. We quantified genome-wide patterns of DNAmethylation at ~400,000 sites in 179
human fetal brain samples (100 male, 79 female) spanning 23 to 184 d post-conception. We identified highly significant
changes in DNA methylation across fetal brain development at >7% of sites, with an enrichment of loci becoming
hypomethylated with fetal age. Sites associated with developmental changes in DNA methylation during fetal brain de-
velopment were significantly underrepresented in promoter regulatory regions but significantly overrepresented in re-
gions flanking CpG islands (shores and shelves) and gene bodies. Highly significant differences in DNA methylation were
observed between males and females at a number of autosomal sites, with a small number of regions showing sex-specific
DNA methylation trajectories across brain development. Weighted gene comethylation network analysis (WGCNA)
revealed discrete modules of comethylated loci associated with fetal age that are significantly enriched for genes involved
in neurodevelopmental processes. This is, to our knowledge, the most extensive study of DNA methylation across human
fetal brain development to date, confirming the prenatal period as a time of considerable epigenomic plasticity.
[Supplemental material is available for this article.]
Human brain development is an intricate process involving the dy-
namic orchestration of gene expression. Prenatal transcriptional
changes in the brainoccurmore rapidly than at anyother stage of life
(Johnson et al. 2009; Colantuoni et al. 2011; Kang et al. 2011). The
precise temporal regulation of transcriptional processes is necessary
for the correct development of structural and functional complexity
in the brain. Although cell-specific and temporally appropriate
gene expression is primarily controlled through the direct action of
transcription factors, there is growing recognition of the role of
epigenetic mechanisms in the dynamic regulation of gene function
during cellular development and differentiation (Henikoff and
Matzke 1997; Jaenisch and Bird 2003; Hirabayashi andGotoh 2010).
DNA methylation is the most extensively studied epigenetic
modification. It is known to play a role in many important genomic
regulatory processes, including X Chromosome inactivation, genomic
imprinting and the repression of tumor suppressor genes in cancer.
DNA methylation refers to the addition of a single methyl group to
carbon five of the cytosine pyrimidine ring, typically in the context of
palindromic 59-CpG-39 dinucleotides, of which there are;28 million
in thehaploidhumangenome, andmore rarely in anon-CpGcontext.
The covalently attached methyl groups project into the major groove
of DNA where they can inhibit transcription by blocking the binding
of transcription factors andby recruitingmethyl-CpGbindingproteins
such as MECP2 which remodel chromatin into a condensed hetero-
chromatic state. Recentworkhas revealed amorenuanced relationship
between DNA methylation and transcription that is dependent on
genomicandcellular context (Jones2012); althoughDNAmethylation
at promoter regulatory regions is typically associated with repressed
expression, DNA methylation in the gene body is often positively
correlated with expression (Ball et al. 2009; Maunakea et al. 2010) and
is thought to play a role in alternative splicing (Maunakea et al. 2013).
The establishment and maintenance of cell-specific DNA
methylationpatterns is crucial for normalmammaliandevelopment
(Reik 2007; Geiman and Muegge 2010; Smith and Meissner 2013;
Ziller et al. 2013). Recent evidence strongly implicates a role for
dynamic epigenetic processes in the regulation of transcriptional
plasticity in the developing brain (Numata et al. 2012; Lister et al.
2013). A critical role for DNA methylation in neurodevelopment is
supported by the dynamic expression of the de novo DNA methyl-
transferases DNMT3A and DNMT3B during prenatal brain
development (Feng et al. 2005), and by the occurrence of neuro-
developmental deficits in humans as a consequence ofmutations in
the methyl-CpG binding protein 2 (MECP2) gene, which interacts
with methylated DNA to control neuronal gene expression (Guy
et al. 2011; Jakovcevski and Akbarian 2012). Furthermore, the dy-
namic regulation of DNA methylation is known to influence key
neurobiological and cognitive functions in the brain across the life
course, including neuronal plasticity (Borrelli et al. 2008; Ma et al.
2010; Guo et al. 2011), memory formation and maintenance (Day
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and Sweatt 2010; Zovkic et al. 2013), and circadian processes (Azzi
et al. 2014). Knowledge about the specific temporal methylomic
changes occurring during human fetal brain development has,
however, been limited due to a lack of tissue samples, with previous
studies focusing on a small number of samples obtained from
a narrow range of fetal ages (Numata et al. 2012; Lister et al. 2013).
Here, we describe an analysis of neurodevelopmental trajec-
tories in DNA methylation in human fetal brain samples, identi-
fying changes to the epigenome during development across
;400,000 sites.
Results
Methodological overview
We assessed genome-wide patterns of DNA methylation in 179
human fetal brain samples (100male, 79 female) spanning 23 to 184 d
post-conception (DPC) (Fig. 1A). Fetal brain tissue was acquired
frozen from the Human Developmental Biology Resource (HDBR)
(http://www.hdbr.org) and MRC Brain Banks network (http://www.
mrc.ac.uk/research/facilities/brain-banks/access-for-research) under
strict ethical regulations and used to isolate genomic DNA.
DNA methylation was quantified using the Illumina Infinium
HumanMethylation450 BeadChip, with preprocessing, normaliza-
tion, and stringent quality control undertaken as previously described
(Pidsley et al. 2013). Our analyses focused on identifying DNA
methylation changes associated with brain development, and
whether these were enriched in certain genomic regions and features
or differed between males and females. We subsequently employed
systems-levelnetwork-basedapproaches to identifymodules ofhighly
comethylated loci and their relationship to fetal brain development.
See the Methods section for an in depth description of the samples
and analytical approaches used in this study.
Human fetal brain development is characterized by widespread
changes in DNA methylation
A combined analysis of all 408,608 probes on the Illumina 450K
array passing stringent quality control (QC) metrics showed that
global levels of DNAmethylation do not change significantly over
the course of human fetal brain development (r = 0.02, P = 0.76)
(Supplemental Fig. 1). In contrast, DNAmethylation at individual
autosomal sites was highly variable across neurodevelopment,
Figure 1. DNA methylation changes during human brain development are widespread across the genome. (A) Overview of the 179 human fetal brain
samples (100male, 79 female) spanning 23 to 184 DPC profiled in this study. (B) Manhattan plot showing the widespread distribution of Bonferroni-significant
fetal brain dDMPs (P-value corresponds to association with age). (C ) The four top-ranked dDMPs showing increased DNA methylation with fetal age (hyper-
methylated dDMPs). DNAmethylation (%) is plotted against DPC. Females are shown in pink,males in blue. (D) The four top-ranked dDMPs showing decreased
DNAmethylationwith fetal age (hypomethylated dDMPs). DNAmethylation (%) is plotted against DPC. Females are shown in pink,males in blue. (E)Many loci
are characterized by regions of extended differential DNA methylation associated with fetal brain development. Shown is the TTYH3 gene that contains three
discrete differentiallymethylated regions (DMRs), which become hypomethylated during fetal brain development. The top panel depicts the association statistic
for individual probes, with color corresponding to significance. The bottom panel depicts the regression coefficient between DNA methylation and brain
development for individual probes, with a line of best-fit highlighting three domains characterized by hypomethylation across brain development.
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Fetal brain methylome
with levels at 28,718 sites (7.19% of the 399,364 autosomal probes
assessed) differing according to fetal age at a significance level
surpassing Bonferroni correction for all tested probes (P < 1.25 3
107) (Fig. 1B). We refer to these as developmentally differentially
methylated positions (dDMPs). The 20 top autosomal dDMPs
(ranked by P-value for age-association), characterized by a positive
correlation between DNA methylation and fetal age (henceforth
referred to as hypermethylated dDMPs), or a negative correlation
(henceforth referred to as hypomethylated dDMPs), are listed in
Table 1. A complete list of all 28,718 significant dDMPs is available
from our laboratory website (http://epigenetics.iop.kcl.ac.uk/
fetalbrain/dDMPs.xls) and in Supplemental File 1. Although the
distribution of dDMPs is relatively consistent acrossmost autosomal
chromosomes (Supplemental Table 1), some chromosomes show
a notable enrichment or depletion of significant sites; for example,
8.87% of CpG probes on Chromosome 13 were identified as Bon-
ferroni-significant dDMPs (relative enrichment = 1.26, P = 3.68 3
1010), whereas only 4.09% of CpG probes on Chromosome 19
reach this criterion (relative enrichment = 0.55, P = 7.01 3 1079).
The four top-ranked hyper- and hypomethylated fetal brain dDMPs
are shown in Figure 1, C and D, respectively. Overall, there is
a highly significant enrichment of hypomethylated autosomal
dDMPs compared with hypermethylated dDMPs (Table 2) (hypo-
methylated sites: n = 16,190 [56.4%]; hypermethylated sites: n =
12,528 [43.6%]; P = 6.743 1053), which is consistentwith previous
reports (Numata et al. 2012). We find a significant correlation (r =
0.57, P = 2.82 3 109) between developmental DNA methylation
changes at the 100 top-ranked fetal cortex dDMPs identified in
a previous, smaller-scale study (Numata et al. 2012) and changes
observed at the same loci in our study (Supplemental Fig. 2).
Althoughwehave not directly generated transcriptomic data on the
samples profiled in this study, fetal brain gene expression data for
loci annotated to the top 20 hypermethylated and top 20 hypo-
methylated dDMPs (listed in Table 1) were extracted from the Brain
Cloud resource (http://braincloud.jhmi.edu) (Colantuoni et al.
2011). This resource contains cortex transcriptomic data from 38
Table 1. Top-ranked autosomal fetal brain dDMPs becoming hyper- and hypomethylated across development
Probe Chr Position Gene Genic probe location
Relation to
CpG island
Regression
coefficient P-value
Hypermethylated DMPs
cg02313829 11 75136574 KLHL35 Body Island 0.27 1.74 3 1022
cg15316843 8 65282946 Island 0.41 4.91 3 1022
cg05881221 2 121200849 Shore 0.36 6.20 3 1021
cg03475293 6 7051303 Shore 0.54 8.51 3 1021
cg21184415 20 39996039 EMILIN3 TSS1500 Shore 0.22 1.03 3 1020
cg25132276 5 149546087 CDX1 TSS1500 Island 0.49 1.21 3 1020
cg10717691 1 210426358 0.34 1.46 3 1020
cg26904169 7 89839865 STEAP2 TSS1500 Shore 0.25 1.89 3 1020
cg10899768 8 102506635 GRHL2 Body Shore 0.31 1.98 3 1020
cg05857996 20 2675418 EBF4 Body Shore 0.21 2.20 3 1020
cg01994290 14 65170049 PLEKHG3 TSS1500 Shore 0.19 2.27 3 1020
cg07458308 5 134827512 Island 0.42 2.40 3 1020
cg10543035 1 179545790 NPHS2 TSS1500 Shore 0.25 2.76 3 1020
cg03689403 12 89749377 Shore 0.34 3.33 3 1020
cg10276869 16 85336004 0.29 4.31 3 1020
cg01429859 1 16163775 Body Island 0.41 5.65 3 1020
cg08238215 2 66673985 MEIS1 Body Shore 0.31 6.39 3 1020
cg08486065 19 3464875 NFIC Island 0.60 7.07 3 1020
cg13187009 20 55965497 RBM38 TSS1500 Shore 0.24 7.52 3 1020
cg01378512 11 126055457 0.51 8.67 3 1020
Hypomethylated DMPs
cg18185980 2 175426016 WIPF1 39 UTR 0.40 2.83 3 1023
cg15632936 5 176216372 0.28 3.93 3 1023
cg04702314 10 75873408 VCL Body 0.36 4.18 3 1023
cg02402882 5 56620429 0.21 9.37 3 1023
cg14394939 21 18983396 BTG3 59 UTR Shore 0.26 1.10 3 1022
cg09130091 6 31838613 SLC44A4 Body 0.23 1.52 3 1022
cg27486692 12 14765994 GUCY2C 39 UTR 0.22 1.68 3 1022
cg13298538 12 1759721 0.27 2.22 3 1022
cg19061798 11 116115813 0.38 2.25 3 1022
cg03581459 14 105780137 PACS2 TSS1500 Shore 0.30 2.30 3 1022
cg06829760 2 16845412 FAM49A 59 UTR 0.33 2.79 3 1022
cg03934354 5 34043140 C1QTNF3 Body; 1st exon 0.37 2.82 3 1022
cg02363655 8 145955421 ZNF251 Body Shore 0.37 2.98 3 1022
cg04314361 2 11850727 0.34 3.25 3 1022
cg21431832 22 26875652 HPS4 TSS200; body Shelf 0.36 5.21 3 1022
cg13609821 7 154705189 Shore 0.47 5.46 3 1022
cg05724065 7 56160528 PHKG1 1st exon; 59 UTR 0.35 5.46 3 1022
cg22788953 7 2679148 TTYH3 Body 0.51 5.61 3 1022
cg12520319 15 101740264 CHSY1 Body 0.43 6.12 3 1022
cg01231009 8 130641185 0.36 6.18 3 1022
Chromosomal coordinates correspond to human genome build Feb. 2009 (GRCh37/hg19). Regression coefficient is the DNA methylation change (%)
per day development. A full list of all 28,718 Bonferroni-significant dDMPs can be downloaded from http://epigenetics.iop.kcl.ac.uk/fetalbrain/dDMPs.
xls and is also given in Supplemental File 1.
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human fetal samples spanning 14 to 20 gestational weeks (;84–126
DPC). Despite the much narrower range of ages in this cohort, nine
(29.03%) of the 31 transcripts for which data were available displayed
a nominally significant (P < 0.05) association between transcript
abundance and brain development (Supplemental Table 2), with
several transcripts showing highly significant associations with de-
velopmental age (Supplemental Fig. 3).ManydDMPsdonot represent
isolated changes at specific sites but rather occur in clusters (Fig. 1E;
Supplemental Fig. 4) representing developmentally differentially
methylated regions (dDMRs).Weused comb-p (Pedersen et al. 2012) to
identify spatially correlated regions of differential DNA methylation
significantly associated with fetal brain development (Sidak-corrected
P < 0.05, number of probes$ 3). In total, 4825 dDMRswere identified
with amean size of 391 base pairs (bp) (SD = 250 bp) and spanning an
averageof 4.77probes (Supplemental Table 3). The top-rankeddDMRs
(ranked by Sidak-corrected P-value) are shown in Supplemental Table
4 and Supplemental Figure 4, and a complete list of all significant
dDMRs is available for download from our laboratory website (http://
epigenetics.iop.kcl.ac.uk/fetalbrain/4825_age_DMRs.csv) and in Sup-
plemental File 2. Of note, several dDMRs are located in the vicinity of
loci known to play a key role in neurodevelopment, including the
Wnt antagonist SFRP1 that regulates cell differentiation and pro-
liferation in the developing brain (Augustine et al. 2001), the nuclear
receptor gene NR4A2, which is important for the differentiation and
maintenanceof dopaminergicneuronsduringneurogenesis (Jankovic
et al. 2005; Vuillermot et al. 2012), and SHANK2, encoding a synaptic
protein that functions as amolecular scaffold in the developing brain
which has been implicated in neurodevelopmental disorders, in-
cluding autism (Schmeisser et al. 2012; Guilmatre et al. 2014).
There is a significant reduction in non-CpG DNA methylation
during human fetal brain development
Of the 408,608 probes passing QC, a small subset (n = 743) in-
terrogated DNA methylation at non-CpG sites. The level of DNA
methylation at these sites is generally low (mean DNA methylation
across all non-CpG sites = 14.93%, SD = 6.83), with the majority of
probes being relatively unmethylated throughout brain de-
velopment, confirming the results of a previous study reporting
negligible levels of non-CpGmethylation in fetal cortex (Lister et al.
2013). There is, however, a small but significant overall decrease in
average non-CpG DNA methylation across the period of fetal brain
development assessed in this study (r =0.24, P-value = 1.143 103)
(Supplemental Fig. 5), with 698 (93.9%) of the interrogatednon-CpG
probes becoming less methylated with developmental age, support-
ing previous data showing that non-CpG methylation is reduced
following differentiation of embryonic stem cells (Lister et al. 2009).
In total, 14 non-CpG sites (1.88%) demonstrated Bonferroni-signif-
icant (P < 6.73 3 105) changes in DNA methylation across brain
development (Supplemental Fig. 6; Supplemental Table 5).
The distribution of fetal brain dDMPs differs depending on CG
density
Although fetal brain dDMPs are seen throughout the genome, they
are not equally distributedwith respect to annotated genic features
(Table 2). There is a significant underrepresentation of dDMPs in
promoter regulatory regions, including CpG islands (CGIs) (per-
centage of significant probes = 1.99%, relative enrichment = 0.26,
P < 3.92 3 10294), genic first exons (percentage of significant
probes = 2.30%, relative enrichment = 0.30, P < 3.92 3 10294),
59 untranslated regions (59UTRs) (percentage of significant probes =
5.17%, relative enrichment = 0.70, P = 3.71 3 1075), and in
the vicinity of annotated transcription start sites (TSSs) (TSS-200:
percentage of significant probes = 2.57%, relative enrichment =
0.34, P < 3.923 10294; TSS-1500: percentage of significant probes =
5.17%, relative enrichment = 0.70, P = 3.34 3 1092) (Fig. 2A).
Conversely, fetal brain dDMPs are significantly enriched in CGI
shores (percentage of significant probes = 8.26%, relative enrich-
ment = 1.16, P = 1.23 3 1028), CGI shelves (percentage of signifi-
cant probes = 8.39%, relative enrichment = 1.18, P = 2.043 1016),
and gene bodies (percentage of significant probes = 8.49%, relative
enrichment = 1.20, P = 4.71 3 1057). Interestingly, dDMPs within
Figure 2. The distribution and direction of fetal brain dDMPs differs
markedly across genomic features. (A) Compared to the genome average,
dDMPs are significantly underrepresented in CpG islands, transcription
start-sites, 59UTRs, and first exons, but significantly enriched in CpG island
shores, CpG island shelves, and the gene body (see also Table 2). (B) There
is an overall enrichment of hypomethylated fetal brain dDMPs (P = 6.743
1053), but CpG islands are unique in showing an enrichment for sites
becoming hypermethylated with fetal brain development (P = 2.00 3
1013) (see also Table 2).
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CGIs are more likely to become hypermethylated with fetal age
(hypermethylated n = 1582 [60.1%] vs. hypomethylated n = 1050
[39.9%], relative enrichment = 1.51, P = 2.003 1013) in contrast to
dDMPs annotated to other genic features, which tend to become
hypomethylated (see Table 2; Fig. 2B). Stratifying genomic regions
by CpG density confirms a highly significant enrichment of dDMPs
in all non-CGI genic features, with the highest percentage of sig-
nificant probes found in non-CGI intergenic sites (percentage of
significant probes = 13.16%, relative enrichment = 1.96, P = 3.923
10294). In contrast, dDMPs were underrepresented in CG-rich re-
gions, especially in CGI proximal promoter sites (percentage of sig-
nificant probes = 0.60%, relative enrichment = 0.08, P < 3.92 3
10294) (Supplemental Table 6; Supplemental Fig. 7).
Fetal brain dDMPs are enriched in certain functional elements
and depleted in others
A modest enrichment of dDMPs compared to the genome average
was seen in DNase I hypersensitivity sites (percentage of significant
probes = 7.53%, relative enrichment = 1.05, P = 3.953 106) (Table 2;
The ENCODE Project Consortium 2012; Slieker et al. 2013) marking
regulatory DNA regions (Maurano et al. 2012). In contrast, probes
associated with transcription factor binding sites (TFBSs) (The
ENCODEProject Consortium2012; Slieker et al. 2013)were under-
enriched for dDMPs compared to the genome average (percentage
of significant probes = 5.75%, relative enrichment = 0.79, P = 1.653
1098). In total, 117 of the 148 (79.05%) classes of TFBS motifs
assessed were significantly (P < 0.05) under-enriched for dDMPs, with
12 (8.11%) being significantly enriched for dDMPs (see Supplemental
Table 7 for a list of under- and over-enriched TFBSs). Taken together,
regions characterized by alternative transcription events (Wang et al.
2008; Koscielny et al. 2009; Flicek et al. 2014; Ensembl, http://www.
ensembl.org) were under-enriched for dDMPs (percentage of signifi-
cant probes = 6.62%, relative enrichment = 0.92, P = 2.22 3 1013)
(Table 2), although there was considerable heterogeneity between
different domains (Supplemental Table 8; Supplemental Fig. 8). There
is a significant over-enrichment of dDMPs in alternative last exons
(percentage of significant probes = 9.82%, relative enrichment = 1.41,
P = 1.05 3 1021), cassette exons (percentage of significant probes =
8.24%, relative enrichment = 1.16, P = 8.09 3 1021), and mutually
exclusive exons (percentage of significant probes = 8.11%, relative
enrichment = 1.14, P = 4.623 105), with all other events displaying
a significant under-enrichment of dDMPs.
There are sex differences and distinct sex-specific
developmental trajectories in the human fetal brain
methylome, including at autosomal locations
A total of 8059 (1.99% of the 408,594 autosomal and X-linked
probes assessed) were identified as significantly (Bonferroni-
corrected threshold: P < 1.22 3 107) differentially methylated
between all male and female samples (Supplemental Fig. 9). As
expected, the majority (n = 7538, 93.53%) of these differences are
located on the X Chromosome and are likely associated with
X Chromosome dosage compensation mechanisms in females.
However, an appreciable proportion of sex differences (n = 521,
6.47%) are autosomal (see Fig. 3A and Table 3 for examples). Of
these, approximately half are hypermethylated in females (n = 261,
50.10%). A full list of all 521 Bonferroni-significant autosomal sex
DMPs can be downloaded from our website (http://epigenetics.
iop.kcl.ac.uk/fetalbrain/sDMPs.xlsx) and is also given in Supple-
mental File 3. Of the 521 sites showing sex differences, 119 overlap
with significant autosomal DNA methylation differences identified
betweenmales and females in a recent analysis of thepostnatal adult
cortex (Xu et al. 2014), with 99.16% (n = 118) of these displaying the
same direction of effect (Supplemental Table 9). Furthermore, there is
a highly significant correlation (r = 0.88, P < 13 10200) between the
magnitude and direction of sex differences in DNAmethylation at
autosomal probes reported as significantly different in the Xu et al.
(2014) analysis of adult brain (n = 544) and sex differences at the
same CpG sites in fetal brain (Supplemental Fig. 10), indicating
that most gender differences in the brain methylome manifest
early in fetal development and are stable across the life course. A
total of 1099 DMRs between males and females in the fetal brain
were identified (Sidak-corrected P < 0.05, number of probes $ 3)
(Supplemental Table 3), of which the majority (n = 908, 82.62%)
are located on the X Chromosome, with 191 (17.38%) located on
the autosomes (see Supplemental Table 10; Supplemental Fig. 11).
A list of all significant sex-associated DMRs is available from
our laboratory website (http://epigenetics.iop.kcl.ac.uk/fetalbrain/
1099_sex_DMRs.csv) and in Supplemental File 4. We next ex-
plored sex-specific changes in DNA methylation across fetal brain
development by analyzing interactions between sex and de-
velopmental age. We identified 61 sites (n = 59 autosomal, n = 2
X Chromosomes) characterized by significant (Bonferroni-corrected
threshold: P < 1.22 3 107) sex-specific DNA methylation trajec-
tories across brain development (Table 4; Supplemental Fig. 12).
The top-ranked autosomal sex-specific dDMP (cg23916284, P =
1.72 3 1010) (Fig. 3B) is located in the gene body of RBPJ, which
encodes a transcriptional regulator in theNotch signaling pathway
that is involved in neurogenesis and neuronal maturation. The
pattern of DNAmethylation observed at this site is typical of other
autosomal sex-specific dDMPs; a high level of DNAmethylation is
observed in both males and females until ;100 DPC, when fe-
males diverge from males, becoming progressively hypometh-
ylated. These findings should be treated with some caution given
the low number of samples at these later gestational ages. The
two significant X Chromosome sex-specific dDMPs (cg09167861
[FHL1], P = 3.50 3 109; cg00718858, P = 9.22 3 108) show more
distinct male and female trajectories across brain development
(Fig. 3C) and potentially reflect dynamic changes inXChromosome
dosage compensation mechanisms. Using comb-p, we identified
66 DMRs displaying sex-specific DNA methylation trajectories
across brain development (Supplemental Fig. 13; Supplemental Ta-
bles 3, 11). A complete list of regions characterized by sex-specific
DNA methylation trajectories can be downloaded from http://
epigenetics.iop.kcl.ac.uk/66_age_sex_DMRs.csv and is also given in
Supplemental File 5.
There are distinct modules of comethylated loci
in the developing human brain
Wenext employedweighted gene comethylation network analysis
(WGCNA) (Langfelder and Horvath 2008) to undertake a systems-
level characterization of the DNA methylation changes associated
with human brain development. WGCNA identified 22 discrete
modules of comethylated positions (Supplemental Table 12), and
the first principal component of each individual module (the
‘‘module eigengene’’) was used to assess their relationship with
fetal brain development (Fig. 4A). Nine modules were found to be
significantly correlated with DPC, most notably the ‘‘yellow’’ (n =
21,999 probes, r = 0.59, P = 3.94 3 1018) and ‘‘brown’’ modules
(n = 24,002 probes, r = 0.54, P = 5.63 3 1015) (Fig. 4B; Supple-
mental Fig. 14). Module membership within these modules is
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highly correlated with probe significance (yellowmodule: r = 0.79,
P < 1 3 10200; brown module: r = 0.72, P < 1 3 10200) (Fig. 4C),
showing a clear relationship betweenDNAmethylation at the core
members of eachmodule and fetal brain development (Fig. 4D). To
test whether the identified modules were biologically meaningful,
over-enrichment analyses (see Methods) were performed using
gene ontology (GO) pathways (Ashburner et al. 2000). Both
modules were highly enriched for specific functional pathways
directly related to development of the nervous system and neu-
robiological function (Supplemental Tables 13, 14). In particular,
the brown module was highly enriched for pathways related to
development of the brain including epithalamus development
(odds ratio = 78.18, P = 3.79 3 1028), central nervous system
neuron axonogenesis (odds ratio = 8.26, P = 9.703 1021), neuron
maturation (odds ratio = 6.97, P = 9.78 3 1015), and nervous
system development (odds ratio = 1.61, P = 1.25 3 1013). In
contrast, modules not associated with fetal brain development
showed no significant enrichment of neurodevelopmental func-
tions (for example, see Supplemental Table 15 for pathways asso-
ciated with the light green WGCNA module). The two modules
strongly associated with sex across all fetal brain samples (light
cyan, Supplemental Table 16; black, Supplemental Table 17) were,
as expected, primarily comprised of X-linked loci and enriched for
pathways relating to epigenetic processes (e.g., negative regulation
of histone H3K36 methylation, odds ratio = 63.83, P = 7.34 3
1018, light cyan module), sex-specific genomic regulation (e.g.,
sex determination, odds ratio = 6.97, P = 7.45 3 1019, black
module), and brain development (e.g., establishment or mainte-
nance of neuroblast polarity, odds ratio = 43.97, P = 7.26 3 1033,
black module). These analyses suggest that the large coordinated
changes in DNA methylation identified across our samples relate
specifically to development of the brain. It is, however, notewor-
thy that a recent ‘‘epigenetic clock’’ algorithm developed by Steve
Horvath (Horvath 2013), based on DNAmethylation values at 353
CpG sites shown to be associated with postpartum age, accurately
predicts that each of our samples is prenatal, with a significant
positive correlation (r = 0.15, P = 0.038) between predicted and
actual age at the resolution of days (Fig. 4E). This supports the
notion that a core set of loci are likely to be more generally asso-
ciated with aging across the life course and that these basic aging
processes start very early in fetal life and occur across tissues.
dDMPs are common in several genomic regions associated with
two neurodevelopmental disorders (schizophrenia and autism)
Schizophrenia and autism spectrum disorder are highly heritable
neuropsychiatric disorders that are believed to have an early neu-
rodevelopmental component (Weinberger 1995; Geschwind and
Figure 3. Sex-specific DNAmethylation differences in the developing fetal brain. A total of 8059 (1.99% of the 408,594 autosomal and X-linked probes
assessed) were identified as significantly differentially methylated between males and females in the fetal brain, with most differences occurring on the X
Chromosome as expected. However, a number of autosomal loci also show significant differences between males and females, as illustrated by the four
probes shown in A. Of note, DNA methylation at a number of (B) autosomal and (C ) X Chromosome probes showed significant interactions between sex
and developmental stage, indicating differential trajectories of DNA methylation in the developing male and female brain.
Spiers et al.
344 Genome Research
www.genome.org
Levitt 2007; Fatemi and Folsom 2009). A recent large-scale genome-
wide association study (GWAS) of schizophrenia (Schizophrenia
Working Group of the Psychiatric Genomics Consortium 2014)
identified 108 conservatively defined loci meeting genome-wide
significance. To aid the functional characterization of these loci and
identify genes potentially involved in the neurodevelopmental
origins of this disorder, we provide annotation of the fetal brain
dDMPs within the 89 genomic regions containing at least one in-
formative CpG site (Supplemental Table 18). Of note, several specific
schizophrenia-associated genomic regions contain multiple dDMPs
(for example, see Fig. 5A,B), highlighting regions of potential interest
for understanding the neurodevelopmental origins of this disorder.
Likewise, for autism, high-confidence candidate gene regions were
selected from the Simons Foundation Autism Research Initiative
(SFARI) gene database (Basu et al. 2009; Abrahams et al. 2013) and
complemented by loci identified in recent exome sequencing and
genomic studies (Neale et al. 2012; O’Roak et al. 2012a,b; Sanders
et al. 2012;Willsey et al. 2013). The number of dDMPs in each of the
genomic regions assessed can be seen in Supplemental Table 19, with
clusters of fetal brain dDMPs observed in the vicinity of autism-as-
sociated genes with known neurodevelopmental functions, in-
cluding NRXN1 (Fig. 5C,D) and SHANK1 (Fig. 5E,F). As autism is
known to have a substantial sex bias (Werling andGeschwind 2013),
we also investigated whether any of the regions containing high-
confidence autism risk genes are subject to sex differences in fetal
brain methylation, which could mediate this effect. Of the 19 ge-
nomic regions investigated, only one autosomal probe, annotated to
SHANK1, displayed sex differences in DNA methylation at a Bonfer-
roni-corrected threshold of P < 7.05 3 105.
Discussion
In this study, we assessed neurodevelopmental methylomic trajecto-
ries in 179human fetal brain samples (100male, 79 female) spanning
23 to 184 DPC. To our knowledge, this represents themost extensive
methylomic studyofhuman fetal brain todate.Ourdata indicate that
considerable epigenomic changes take place in the human brain
during fetal brain development. We observe Bonferroni-significant
changes in DNA methylation at >7% of sites assessed, with sex-spe-
cific methylomic trajectories observed for multiple dDMPs including
dDMPs on autosomes. Our data also reveal modules of comethylated
loci associated with fetal age, which are significantly enriched for
genes involved in neurodevelopmental processes.
Although there is an overall enrichment of sites becoming less
methylatedduring fetal braindevelopment, several genomic regions
are characterized by distinctly different developmental patterns.
DNA methylation in CpG-rich regions, for example, appears to be
considerably less dynamic during fetal brain development than
other genomic regions. Furthermore, althoughCpG-rich regions are
characterized by an enrichment of hypermethylated sites compared
to hypomethylated sites, the majority of dDMPs in the genome
become hypomethylated with brain development. It is not surpris-
ing that CpG islands are relatively less dynamic than other regions
interrogated in this study given their role in regulating the stable
expression of key housekeeping loci (Deaton and Bird 2011). Addi-
tionally, we observe an enrichment of dDMPs within the gene body,
and these sites tend to display decreasing levels of DNAmethylation
with age. Interestingly, gene body DNA methylation is often posi-
tively correlated with gene expression (Ball et al. 2009; Maunakea
et al. 2010) and has been hypothesized to enhance transcription
elongation efficiency, suppress the spurious initiation of transcrip-
tion within active genes, contribute to splicing mechanisms, and
regulate alternative promoter use. These changes in gene body DNA
methylation during brain development is therefore interesting
given the dramatic transcriptional plasticity occurring in the brain at
this time (Colantuoni et al. 2011).
Due to the differences in prevalence observed between males
and females for many neurodevelopmental disorders, it is impor-
tant to understand sex-specific processes in brain development
(Baron-Cohen et al. 2005). Our data demonstrate notable sex
differences in the fetal brain methylome, including at autosomal
loci. Many of these overlap with autosomal DNA methylation sex
differences in the adult cortex (Xu et al. 2014), indicating that sex-
differences in the brain methylome manifest during fetal
Table 3. The 20 top-ranked autosomal sex differences in DNA methylation in the fetal brain
Probe P-value Chr Position Gene(s)
Genic
probe location
Relation to
CpG island
Male
mean
Male
SD
Female
mean
Female
SD
Difference
(Female - Male)
cg12691488 1.66 3 1080 1 243053673 Island 36.11 4.08 15.28 3.87 20.83
cg03691818 7.59 3 1069 12 53085038 KRT77 Body 9.06 1.00 16.08 2.15 7.01
cg11643285 8.78 3 1065 3 16411667 RFTN1 Body 72.38 2.79 83.76 2.95 11.38
cg02325951 1.99 3 1054 14 89878619 FOXN3 Body Shelf 78.28 4.48 65.08 3.17 13.20
cg03687700 9.76 3 1053 2 24271844 FKBP1B TSS1500 Shore 20.43 3.18 32.55 4.28 12.12
cg04946709 1.05 3 1048 16 59789030 Body Island 84.30 2.49 76.47 2.56 7.83
cg15817705 5.81 3 1047 1 209406063 Shore 84.38 2.60 75.70 3.22 8.67
cg22345911 4.08 3 1045 17 80231263 CSNK1D 59 UTR; 1st exon Island 10.24 0.74 12.67 0.95 2.43
cg23719534 2.17 3 1043 15 101099284 Island 82.86 2.76 90.64 2.79 7.77
cg11841231 2.20 3 1038 2 205543309 PARD3B Body 78.89 3.29 68.67 4.83 10.22
cg06710937 6.65 3 1038 13 23489940 Island 8.63 0.70 12.23 2.03 3.59
cg23001456 2.45 3 1036 17 2615074 CLUH TSS200 Island 8.51 0.60 10.00 0.66 1.49
cg03218192 1.23 3 1033 17 33914403 AP2B1 1st exon; 21.11 2.25 26.58 2.56 5.46
cg06642617 5.05 3 1033 2 73461528 CCT7 Body; TSS1500; 59 UTR Island 8.37 1.17 6.30 0.41 2.07
cg04874129 5.48 3 1033 16 55690873 SLC6A2 1st exon Island 11.87 1.98 16.22 1.94 4.36
cg24016844 5.25 3 1031 1 111506641 LRIF1 TSS200 Island 16.04 2.18 12.08 1.38 3.97
cg22921760 2.63 3 1030 14 22005368 SALL2 TSS200 24.40 2.76 30.36 2.95 5.96
cg21148594 3.50 3 1029 14 65704156 68.33 4.05 60.69 3.79 7.64
cg12614789 3.72 3 1028 15 76638473 Island 15.81 2.57 21.02 2.79 5.22
cg09971754 4.15 3 1028 16 89557657 ANKRD11 TSS1500 Island 11.15 1.70 8.22 1.12 2.93
Mean and standard deviation (SD) represent DNA methylation (%). A full list of all 521 Bonferroni-significant autosomal sex DMPs can be downloaded
from http://epigenetics.iop.kcl.ac.uk/fetalbrain/sDMPs.xlsx and is also given in Supplemental File 3.
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development and are stable across life. We also identify sex dif-
ferences in DNA methylation trajectories across fetal brain de-
velopment, with DNA methylation at a number of loci showing
significant interactions between sex and fetal age. The top-ranked
CpG site showing a sex-specific neurodevelopmental trajectory is
located in the RBPJ gene, which encodes a transcriptional regulator
in the Notch signaling pathway that is directly involved in neuro-
genesis and neuronal maturation (Louvi and Artavanis-Tsakonas
Table 4. Age-sex interactions in DNA methylation during human brain development
Probe Chr Position Gene(s) Genic probe location Relation to CpG island P-value
cg23916284 4 26358537 RBPJ Body; 59 UTR Shelf 1.72 3 1010
cg18256640 15 26047382 ATP10A Body 3.29 3 1010
cg05919461 4 77688155 SHROOM3 Body 3.44 3 1010
cg19905213 2 81122587 3.58 3 1010
cg02179478 3 35785377 MIR128-2; ARPP-21 TSS1500; Body 1.05 3 109
cg06413196 7 640338 PRKAR1B Body Shelf 1.24 3 109
cg01077501 7 134617592 CALD1 Body 2.20 3 109
cg11881599 12 92814084 CLLU1OS; CLLU1 39 UTR; TSS1500 2.75 3 109
cg00908690 14 90135319 2.89 3 109
cg03664772 7 786682 HEATR2 Body 3.01 3 109
cg07928191 4 1205359 CTBP1 39 UTR Shore 3.33 3 109
cg09167861 X 135251741 FHL1 Body; 1st exon; 59 UTR; TSS200 3.50 3 109
cg25015813 12 127226110 4.20 3 109
cg07997529 6 142682670 GPR126 Body 4.25 3 109
cg07936800 2 151558015 4.54 3 109
cg17440077 20 18122816 PET117; CSRP2BP Body; TSS200 Shelf 4.80 3 109
cg07689396 7 633050 PRKAR1B Body Shore 5.50 3 109
cg13021479 17 8380298 MYH10 Body Island 5.51 3 109
cg17342469 22 46473074 7.30 3 109
cg05696811 16 87725895 JPH3 Body Shore 7.59 3 109
cg01502919 6 124122318 Shore 7.86 3 109
cg22987078 20 62550653 MIR941-3; MIR941-2;
MIR941-1; DNAJC5
TSS1500; TSS200; 59 UTR Shore 8.05 3 109
cg24150325 5 121739336 SNCAIP Body 1.04 3 108
cg14027297 22 26911633 Shelf 1.04 3 108
cg05596468 8 1885915 ARHGEF10 Body 1.10 3 108
cg04654132 2 191881917 Shelf 1.33 3 108
cg13621836 8 1885886 ARHGEF10 Body 1.89 3 108
cg16724800 1 121259813 TSS1500 Shore 2.44 3 108
cg14373380 1 16268457 ZBTB17 39 UTR Shore 2.47 3 108
cg09887323 1 6348460 ACOT7 Body 2.89 3 108
cg13995568 6 119774243 3.02 3 108
cg16515477 1 49511332 AGBL4 Body 3.03 3 108
cg16439394 7 632926 PRKAR1B Body Shore 3.05 3 108
cg15381475 7 6436101 RAC1 Body 3.14 3 108
cg05712435 16 19185556 SYT17 Body 3.38 3 108
cg15866542 12 27658169 4.32 3 108
cg24965322 7 131810054 PLXNA4 39 UTR 4.46 3 108
cg14989661 3 38216354 OXSR1 Body 4.73 3 108
cg10517202 3 177187243 4.75 3 108
cg15770585 7 4762742 FOXK1 Body Shore 4.87 3 108
cg07746960 19 42546662 GRIK5 Body Island 4.94 3 108
cg27338353 22 46471129 Shelf 5.11 3 108
cg14274759 2 43999864 DYNC2LI1 TSS1500 5.42 3 108
cg08006956 19 18418056 LSM4 39 UTR Shelf 5.84 3 108
cg02081841 10 80590072 6.07 3 108
cg20038366 8 1885997 ARHGEF10 Body 6.51 3 108
cg25495650 7 633202 PRKAR1B Body Shore 6.76 3 108
cg02724647 22 17646207 CECR5-AS1 Body; TSS200 6.91 3 108
cg03719152 7 640381 PRKAR1B Body Shelf 6.93 3 108
cg20364574 6 169475525 7.23 3 108
cg17075096 10 124623239 FAM24B 59 UTR 7.51 3 108
cg07481031 2 192890299 TMEFF2 Body 8.16 3 108
cg17670512 17 80627720 RAB40B Body 9.04 3 108
cg07264238 17 33474376 UNC45B TSS1500 9.14 3 108
cg00718858 X 50024233 Shore 9.22 3 108
cg03613618 8 97658325 CPQ 59 UTR Shore 1.01 3 107
cg02806675 3 59627287 1.09 3 107
cg10623530 7 640409 PRKAR1B Body Shelf 1.11 3 107
cg00908927 11 79152969 TENM4 TSS1500 Shore 1.17 3 107
cg02104893 6 123109391 SMPDL3A TSS1500 Shore 1.18 3 107
cg22835712 2 102737379 1.20 3 107
DNA methylation at 61 CpG sites was characterized by Bonferroni-significant interaction between developmental stage (DPC) and sex. Chromosomal
coordinates correspond to human genome build Feb. 2009 (GRCh37/hg19). Examples of specific interactions are shown in Figure 3, B and C.
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Figure 4. Gene comethylation modules in the developing human brain. (A) Heatmap representing the correlation between module eigenvalues (ME)
and the samples traits of DPC and sex. Each row represents a module, as indicated on the y-axis, and each column a trait. As shown in the color scale bar,
strong positive correlation is indicated by dark red, strong negative correlation is indicated by dark green, and white indicates no correlation. Each cell
contains the corresponding correlation and P-value given in parentheses. The yellow (P = 3.943 1018) and brown (P = 5.633 1015) WCGNAmodules
are most significantly associated with human fetal brain development. (B) The module eigengene of the yellow and brownmodules is significantly associated
with brain development, and (C )modulemembership in bothmodules is strongly correlatedwith probe significancewith brain development (yellowmodule:
r = 0.79, P < 13 10200; brownmodule: r = 0.72, P < 13 10200). Probe significance is the absolute value of the correlation between DNAmethylation
at a CpG site and developmental age, andmodulemembership is defined as the correlation between themodule eigengene and the probemethylation
profile. (D) Heatmap of probes in the yellow and brown modules showing changes across brain development. Color corresponds to DNA
methylation level at probes with a module membership >0.85. (E) There is a significant correlation (r = 0.15, P = 0.038) between predicted and actual
age at the resolution of days.
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Figure 5. Fetal brain dDMPs in the vicinity of genetic loci associated with neurodevelopmental disorders. (A) Fetal brain dDMPs within high-
confidence regions identified in a recent large GWAS of schizophrenia may provide insight regarding causal variants, e.g., region Chr 20: 37361494–
37485994 contains two genes, of which one overlaps with five highly significant dDMPs: PPP1R16B. The position of the most significant SNP
(rs6065094) is indicated by a dashed red line. (B) The top-ranked dDMP (cg26680502) in the schizophrenia-associated region displays significant
hypermethylation across fetal brain development (P = 9.513 1016). (C ) Examples of dDMPs in the vicinity of autism candidate gene NRXN1, with (D)
the top-ranked NRXN1 probe (cg23851515) becoming significantly hypomethylated across fetal brain development (P = 3.233 1014). (E) Examples
of dDMPs in the vicinity of autism candidate gene SHANK1, with (F) the top-ranked probe (cg01427575) becoming significantly hypomethylated
across fetal brain development (P = 5.91 3 109).
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2006; Fujimoto et al. 2009; Imayoshi et al. 2010). Of note, recent
evidence suggests there is considerable interaction between Notch
signaling and sex hormones including estradiol (Soares et al. 2004;
Arevalo et al. 2011; Ruiz-Palmero et al. 2011). Sex hormones are
believed to contribute to the sexual differentiation of the brain that
occurs in the second half of pregnancy (Bakker and Brock 2010) and
are known to be potent modifiers of epigenetic status and tran-
scription in the brain (Ghahramani et al. 2014). In this regard, it is
interesting thatmale-female divergence atmany loci occurs at;100
DPC (see Fig. 3B), coinciding with a testosterone peak occurring
between weeks 12 and 18 of pregnancy that is believed to mediate
sexual differentiation of the brain (Finegan et al. 1989).
Schizophrenia and autism spectrum disorder are common
neuropsychiatric disorders that are believed to have an early neu-
rodevelopmental component (Weinberger 1995; Geschwind and
Levitt 2007; Fatemi and Folsom 2009). Understanding the epi-
genomic changes occurring during fetal brain development could
therefore provide useful insight about the molecular etiology of
these conditions, especially given recent evidence for disease-asso-
ciated epigenetic dysfunction in the brain (Mill et al. 2008; Ladd-
Acosta et al. 2013; Pidsley et al. 2014). We include the location of
dDMPs in relation to high-confidence schizophrenia- and autism-
associated loci, which could provide clues to the location of func-
tional genetic variants contributing to the etiologyof these disorders.
There are several limitations to this study. First, legal restrictions
on later-term abortions precluded the assaying of brain samples from
later stages of fetal development. However, in comparison with pre-
vious studies,wehaveassessed amuch largernumberof brain samples
spanning a wider range of fetal ages (Numata et al. 2012; Lister et al.
2013). For example, the largest previous study (Numata et al. 2012)
assayed only 30 prenatal samples spanning ;100 to 130 DPC. An-
other limitation is that the brain tissue used in the present study was
acquired frozen and undissected, and was therefore processed as
a composite of brain regions and cell types. Although this precludes us
from specifying a particular brain region or cell type from which our
data are derived, our results have the potential advantage of being
representative of the predominant changes in the developing human
brain as a whole. Third, although the Illumina 450K platform can
accurately quantify DNA methylation at single-base resolution with
probes associated with 99% of genes and 96% of CGIs, the array tar-
gets <2% of the CpG sites in the human genome, and probes are not
equally distributed across all genomic features. As costs diminish,
future studies should employ sequencing-based genomic-profiling
technologies to more thoroughly interrogate the epigenome
across development in large numbers of samples. Fourth, it is likely
that the Bonferroni-corrected P-value cutoff applied in this study is
overly conservative due to the nonindependence of CpG sites
(Shoemaker et al. 2010). Although we report that ;7% of probes
represent true fetal brain dDMPs, the reality is likely to be higher.
Fifth, no demographic or phenotypic information other than de-
velopmental age was available for the samples assayed, although we
were able to determine sex using anXYChromosome PCR assay and
the DNA methylation data. Sixth, we do not have gene expression
data from these samples and are therefore unable to make direct
conclusions about the transcriptional consequences of the de-
velopmental changes in DNA methylation we observe. Using pub-
licly availablemicroarray gene expression data from an independent
set of fetal brain samples, however, we find evidence that a number
of genes in the vicinity of our top-ranked dDMPs are differentially
expressed across brain development. Given the low number of
samples and limited developmental ages available in the resource
utilized (Colantuoni et al. 2011), as well as the lack of information on
alternative splicing and isoform abundance, these data suggest that
manyof the fetal braindDMPswill have transcriptional consequences
in the developing brain. Finally, we are not able to distinguish be-
tween DNA methylation and its oxidized derivative, DNA hydroxy-
methylation, as standard bisulfite sequencing does not distinguish
between thesemodifications (Huang et al. 2010). This is an important
confounder given that the latter is known to be abundant and to have
functional relevance in the brain (Globisch et al. 2010; Khare et al.
2012; Lister et al. 2013). It will therefore be important to further
characterize thesemodifications across fetal brain development using
techniques capable of discriminating DNA methylation and DNA
hydroxymethylation (Booth et al. 2012), as well as additional epi-
genetic modifications, including the more highly oxidized DNA
methylation derivatives, 5-formylcytosine and 5-carboxycytosine,
and histone modifications (Plongthongkum et al. 2014).
In conclusion, we identify highly dynamic hypo- and
hypermethylation occurring throughout the genome during hu-
man fetal brain development, with notable sex-specific meth-
ylomic trajectories observed for several dDMPs. There are discrete
modules of comethylated loci associated with brain development
that are significantly enriched for genes involved in neuro-
developmental processes. Our data indicate that epigenetic
changes during human brain development are highly dynamic,
sometimes sex-specific, and may provide clues to the origins of
common neurodevelopmental disorders.
Methods
Samples
Human fetal brain tissue was acquired from the Human De-
velopmental Biology Resource (HDBR) (http://www.hdbr.org) and
the MRC Brain Banks network (http://www.mrc.ac.uk/research/
facilities/brain-banks/access-for-research). Ethical approval for the
HDBR was granted by the Royal Free Hospital research ethics
committee under reference 08/H0712/34 and Human Tissue Au-
thority (HTA) material storage license 12220; ethical approval for
the MRC Brain Bank was granted under reference 08/MRE09/38.
The age of these samples ranged from 23 to 184 DPC, determined
by Carnegie staging in the case of embryonic samples (defined as
#56 DPC) and foot and knee to heel lengthmeasurements for fetal
samples (defined as $57 DPC). No additional phenotypic or de-
mographic information was available. An overview of the samples
is given in Figure 1A and Supplemental Table 20. Brain tissue was
obtained frozen and had not been dissected into regions. We
therefore homogenized half of the brain tissue from each in-
dividual fetus for subsequent genomic DNA extraction, which was
performed by standard phenol-chloroform procedures. Sample sex
was determined via PCR amplification of a region in the vicinity of
the amelogenin gene (AMELY) that produces different sized PCR
products for the X and Y Chromosomes (977 and 788 bp, re-
spectively) (Eng et al. 1994). Following methylation array pro-
cessing, sex-calls were confirmed using multidimensional scaling
plots of the variable XY Chromosome probes (see below).
Genome-wide DNA methylation quantification
All samples were randomized with respect to age and sex to avoid
batch effects throughout all experimental procedures. Genomic
DNA (500 ng) from each sample was treated in duplicate with so-
dium bisulfite using the Zymo EZ DNAMethylation-Lightning Kit
(Zymo Research). Genome-wide DNA methylation was quantified
using the Illumina Infinium HumanMethylation450 BeadChip
(Illumina) and scanned on the HiScan System (Illumina). Illumina
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GenomeStudio software (Illumina) was used to extract signal in-
tensities for each probe, generating a final report thatwas imported
into the R statistical environment 3.0.2 (http://www.r-project.org)
(R Development Core Team 2005) using the methylumi and minfi
packages (http://www.bioconductor.org/packages/release/bioc/html/
methylumi.html). Data quality control and preprocessing were per-
formed using the wateRmelon package as described previously
(Pidsley et al. 2013). Stringent filtering of the prenormalized Illu-
mina 450K data was performed using the pfilter function; CpG sites
with a beadcount of <3 in 5% of samples were removed (n = 146) as
were CpG sites with a detection P-value > 0.05 in 1% of samples
(n = 22,379). Finally, cross-reactive probes and polymorphic CpGs,
as detailed in the Illumina annotation file and identified in recent
publications (Chen et al. 2013; Price et al. 2013), were removed
(Supplemental Table 21), leaving 408,608 probes for further anal-
ysis (including n = 9230XChromosome and n = 14 YChromosome
probes). Data were normalized with the dasen function of the
wateRmelon package. Demographic information for the final
cohort of the 179 samples remaining following quality control
(n = 100 males [age range = 23 to 184 DPC]; n = 79 females [age
range = 37 to 161 DPC]) is shown in Supplemental Table 20.
Statistical analysis
A multiple linear regression model with DPC and sex was used to
identify methylation changes associated with brain development
or sex. Autosomal probes (n = 399,364) were considered signifi-
cantly associated with DPC if they passed a Bonferroni-corrected
significance threshold of P < 1.25 3 107 (a = 0.05), while auto-
somal andXChromosome probes (n = 408,594) were considered to
be significantly associated with sex if they passed a Bonferroni-
corrected significance threshold of P < 1.22 3 107 (a = 0.05). The
model was then extended to include an interaction term between
sex and DPC and fitted for all autosomal and X-linked probes (n =
408,594); a significance threshold of P < 1.223 107 (a = 0.05) was
used to identify probes with different developmental methylation
trajectories between the sexes.
WGCNA analysis
Weighted gene comethylation network analysis (WGCNA)
was used to identify modules of highly comethylated probes
(Langfelder and Horvath 2008). Modules were identified from
their pairwise correlations, using a signed block-wise network con-
struction at power 4.Modules identifiedwere assigned a color name,
and a weighted average-methylation profile, known as a module
eigengene (ME), was calculated for each. Correlations between the
MEs and the phenotypic traits available (DPC, sex) were used to
identify modules associated with these traits. The relationship be-
tween each probe and each module was assessed through calcula-
tionofmodulemembership (MM), the absolute correlationbetween
a probe’s DNA methylation status and the ME, allowing the iden-
tification of the subset of probes with the strongest membership to
each module. Probe significance (PS), the absolute value of correla-
tion between each probe and phenotypic trait, was calculated to
quantify the association of probes with age. To assess the biological
meaning of modules associated with age and sex, genes associated
with probes possessing an absolute MM value of >0.85 were
extracted and assessed using pathway and gene ontology analysis.
Gene ontology and pathway analysis
Gene annotations provided by Illumina were used to map probes
to genes. Gene ontology terms were downloaded and annotated to
all probes based on these gene annotations where all parent terms
for each child term were also included. Probes without genic an-
notation or without any gene ontology annotation were excluded
from the subsequent analysis. Fisher’s exact tests were used to test
for an over-enrichment of WGCNA module probes in each path-
way compared to all probes passing QC and inputted to the
WGCNA algorithm. Only pathways containing at least 50 probes
were considered. By running the analysis at the probe level, we
were able to control for the uneven distribution of probes per gene,
minimizing any bias introduced by genes with an above average
number of probes.
Enrichment analyses in genomic regions associated with autism
Candidate loci were selected from the SFARI gene database
(selecting genes having an evidence level of 1 [high confidence] or
2 [strong candidate]) (Basu et al. 2009; Abrahams et al. 2013),
supplementedwith genes implicated by exome sequencing studies
(Neale et al. 2012; O’Roak et al. 2012a,b; Sanders et al. 2012), as
well as those identified as high-confidence ASD genes in a recent
study (Willsey et al. 2013). Probes annotated to these genes were
tested for enrichment of dDMPs using with a two-tailed Fisher’s
exact test, compared to the frequency of dDMPs in all gene-
annotated probes on the Illumina 450K array (38,845 [11.03%] of
352,191 probes).
Data access
Raw and normalized Illumina 450K methylation data has been
submitted to the NCBI Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo/) under accession number GSE58885.
A searchable database of our fetal brain DNA methylation data is
available at http://epigenetics.iop.kcl.ac.uk/fetalbrain.
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